Corrigendum to "Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 116 (2023) 109795]
Int Immunopharmacol. 2024 Dec 18:113849.
doi: 10.1016/j.intimp.2024.113849.
Online ahead of print.
1 Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, Hubei, China; Hubei Key Laboratory of Cardiology, Wuhan 430060, Hubei, China.
2 Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, Hubei, China; Hubei Key Laboratory of Cardiology, Wuhan 430060, Hubei, China. Electronic address: [email protected].
3 Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China; Cardiovascular Research Institute of Wuhan University, Wuhan 430060, Hubei, China; Hubei Key Laboratory of Cardiology, Wuhan 430060, Hubei, China. Electronic address: [email protected].